在国内外重要学术刊物（NatureEnergy,Energy&EnvironmentalScience,ACSNano,J.Phys.Chem.C，JMC,CEJ,ACSAppl.Mater.Interface，ScienceChinaChemistry等）上发表学术论文150余篇，其中SCI/...

在国内外重要学术刊物（NatureEnergy,Energy&EnvironmentalScience,ACSNano,J.Phys.Chem.C，JMC,CEJ,ACSAppl.Mater.Interface，ScienceChinaChemistry等）上发表学术论文150余篇，其中SCI/...

JMCMurtuzaHadianawalaFutureofMedicine:HowSmallMoleculesandBiologicsComplementEachOther─AMedicinalChemist\'...69(14):16130-16134.10.1021/acs.jmedchem.6c02013ACS

Synthesis,andSARofCovalentKITandPDGFRAInhibitorsExploringTheirPotentialinTargetingGISTJournalofMedicinalChemistry2025202568(3):3238–3259.10.1021/acs.jmedchem.4c02472...

KarenY.Chen;...OrallyBioavailableSmall-MoleculeInhibitorofWildtypeKITwithExceptionallyHighKinomeSelectivityJournalofMedicinalChemistry2026无10.1021/acs.jmedchem.6c00898...

JMC文献求助有链接J.Med.Chem.(2006)49(6):1900–1909.ASystematicStudyofC-GlucosideTrisphosphatesasmyo-InositolTrisphosphateReceptorLigands.Synthesisofβ-C-...1900–1909.J.Med.Chem....

求助一篇JMC123DiscoveryofQuinazolineandQuinoline-...9260–9276...

JamesCregg等DiscoveryofDaraxonrasib(RMC-6236),...Issue6，6064–608310.1021/acs.jmedchem.4c02314https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c02314?ref=article_openPDFACS

yalongLiValine-Alanine-BasedPeptidomimeticLinkerforAntibody-DrugConjugatesJMC不清楚不清楚https://doi.org/10.1021/acs.jmedchem.5c03548

ChinaMorebyYuhuiMiaoDounanXuXuYangHanruiSunYipanLuoXiaochenLiangShuangHuXiaoLinJingGaoXiaolinLuoYiPan*HuanXiong*ChengLuo*ShijieChen*...

0077(Inavolisib),aHighlySelectiveInhibitorandDegraderofMutantPI3KαJournalofMedicinalChemistry,2022,vol.65,#24,p.16589-16621https://doi.org/10.1021/acs.jmedchem.2c01422

JamesCregg*AnneV.EdwardsStephanieChangBiancaJ....J.Med.Chem.2025,68,6,6064–6083JournalofMedicinalChemistryCitethis:J.Med.Chem.2025,68,6,6064–608310.1021/acs.jmedchem.4c02314...

in-ClassG9a/GLPCovalentInhibitorsJournalofMedicinalChemistry202265,15,10506–10522https://pubs.acs.org/doi/10.1021/acs.jmedchem.2c00652ACS

求JMC一篇XiaoshenMa*DavidL.Sloman*TimothyJ.Henderson*D.JonathanBennettGianniChessariPhilipJ....BasedDrugDesignJournalofMedicinalChemistry2026-...

MagnusPfaffenbach*PhilippeN....8169─AHighlyPotent,Selective,andBrain-PenetrantIRAK4InhibitorfortheTreatmentofNeuroinflammationJ.Med.Chem.2024,67,10,8383–8395...

PatrickM?derLarsKattner*...CurrentStatusandPerspectiveonanEmergingFunctionalGroupinMedicinalChemistryjournalofmedicinalchemistry202063,23,14243–1427510.1021/acs.jmedchem.0c00960...

SnahelPatel*HuifenChenEugeneVarfolomeevDiscoveryofClinicalCandidateGDC-8264,aNovel,PotentandSelectiveRIP1...21,23050–23077org/10.1021/acs.jmedchem.5c01891

这些分子具有新颖的抗菌作用模式，例如膜-蛋白双重靶向（2014JACS4，2014JMC5，2015PNAS6）、膜-DNA双重靶向（2021SciAdv7，2024SciAdv8，2021Biomaterials9，...A-有机合成，B-动物实验，C-...

ZonghuiMaJiaZhouNDASubmissionofVepdegestrant(ARV-471)toU.S.FDA:TheBeginningofaNewEraofPROTACDegradersJ.Med.Chem.2025,68,14,14129–1413610.1021/acs.jmedchem.5c01818...

MarkusSchade*JamesS.ScottThomasG.HayhowAndyPikeInaTerstiegeMarieAhlqvistJohanR....15,13106–1311610.1021/acs.jmedchem.4c01017https://doi.org/10.1021/acs.jmedchem.4c01017ACS

NDiscoveryofReversibleCovalentBruton’sTyrosineKinaseInhibitorsPRN473andPRN1008(Rilzabrutinib)JournalofMedicinalChemistry202265(7),5300?531610.1021/acs.jmedchem.1c01170...

PankajBhattaraiTrevorA.TrombleyRyanA.Altman*MetabolicStabilityofFluorinatedSmallMolecules:...doi.org/10.1021/acs.jmedchem.5c02359ACS

GuidedDesignofPotentandSelectiveCovalentInhibitorsTargetingtheSARS-CoV-2Papain-likeProteaseJournalofMedicinalChemistry2026XXXX,XXX,XXX-XXX10.1021/acs.jmedchem.5c01973...

1528210.1021/acs.jmedchem.2c01218https://pubs.acs.org/doi/10.1021/acs.jmedchem.2c01218ACSJMedChem,2022,65,15282

2022,vol.65,#7,p.5300-5316https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c01170